Emphasize the Risks of Tianeptine
August 2025
Tianeptine is making headlines...based on recent US warnings about risk of serious harm or death.
Tianeptine is approved in some Asian, European, and Latin American countries as an atypical antidepressant. It works by modulating glutamate...and it’s an opioid receptor agonist.
But it’s not approved in Canada for any use.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive